People who quit taking popular GLP-1 drugs such as Ozempic might their jeopardize heart health, according to a new study.

People take GLP-1 drugs like Wegovy, Ozempic, Mounjaro, and Zepbound for a variety of reasons, from controlling diabetes and sleep apnea to managing weight and enjoying benefits to the heart, liver, ...

A new study suggests that almost half of people stopping GLP-1 weight-loss drugs may keep the weight off. However, many of these people continued other forms of treatment after stopping GLP-1 drugs.

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) ...

Experimenters hope to harness the powerful effects of medications such as Ozempic and Wegovy at doses smaller than those studied most.

As use of GLP-1 medications surges, tools like Weight Loss Buddy emerge as critical infrastructure for sustaining ...

GLP-1 drugs can suppress thirst cues, leading to dehydration exacerbated by side effects like nausea and diarrhea. There's an ...

Stopping GLP-1 medications is linked to a higher risk of heart attack, stroke, and death. Recent research found that even ...

Continuous use of GLP-1 receptor agonists in adults with type 2 diabetes was associated with a lower risk of major ...

Doctors explain the differences between the Wegovy pill and injection in terms of efficacy, side effects, and more. They ...

A new study suggests heart health gains disappear in half the time it takes to build them up when people stop taking GLP-1 ...

At least a dozen large Indian drugmakers are set to roll out copies of Novo Nordisk A/S’s blockbuster weight-loss drugs as soon as the patent expires Friday, crashing prices in the country with the ...